Common Contracts

930 similar Underwriting Agreement contracts by Waystar Holding Corp., StandardAero, Inc., Viking Holdings LTD, others

GRID DYNAMICS HOLDINGS, INC. Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • November 14th, 2024 • Grid Dynamics Holdings, Inc. • Services-prepackaged software • New York

Grid Dynamics Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 5,750,000 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 862,500 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

AutoNDA by SimpleDocs
VERA THERAPEUTICS, INC. 7,142,858 Shares of Class A Common Stock Underwriting Agreement
Underwriting Agreement • October 31st, 2024 • Vera Therapeutics, Inc. • Pharmaceutical preparations • New York

Vera Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC (“J.P. Morgan”), Goldman Sachs & Co. LLC (“Goldman Sachs”), Evercore Group L.L.C. (“Evercore”) and Cantor Fitzgerald & Co. (“Cantor”) are acting as representatives (the “Representatives”), an aggregate of 7,142,858 shares (the “Underwritten Shares”) of Class A common stock, par value $0.001 per share, of the Company and, at the option of the Underwriters, up to an additional 1,071,428 shares of Class A common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Class A common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Septerna, Inc. [•] Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • October 21st, 2024 • Septerna, Inc. • Pharmaceutical preparations • New York
CRINETICS PHARMACEUTICALS, INC. 10,000,000 Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • October 9th, 2024 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 10,000,000 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to 1,500,000 additional shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Upstream Bio, Inc. [•] Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • October 7th, 2024 • Upstream Bio, Inc. • Pharmaceutical preparations • New York
MOOVE LUBRICANTS HOLDINGS [25,000,000] Common Shares, par value US$0.000333333333333 per share Underwriting Agreement
Underwriting Agreement • October 1st, 2024 • Moove Lubricants Holdings • Miscellaneous products of petroleum & coal • New York

Moove Lubricants Holdings, a Cayman Islands exempted company with limited liability (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [6,250,000] common shares, par value US$0.000333333333333 per share, of the Company, the shareholder of the Company named in Section 1 of Schedule 2 hereto (“Cosan”) and the shareholder of the Company named in Section 2 of Schedule 2 hereto (the “CVC Fund VII” and, together with Cosan, the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of [18,750,000] common shares of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [3,750,000] common shares of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein refer

STANDARDAERO, INC. 60,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • September 27th, 2024 • StandardAero, Inc. • Aircraft engines & engine parts • New York

StandardAero, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 53,250,000 shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”), and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of 6,750,000 shares of Common Stock of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional 9,000,000 shares of Common Stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “St

camp4 therapeutics corporation [•] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • September 26th, 2024 • Camp4 Therapeutics Corp • Pharmaceutical preparations • New York

CAMP4 Therapeutics Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

INVENTRUST PROPERTIES CORP. 8,000,000 Shares of common stock, $0.001 par value per share Underwriting Agreement
Underwriting Agreement • September 25th, 2024 • InvenTrust Properties Corp. • Real estate investment trusts • New York

InvenTrust Properties Corp., a Maryland corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 8,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,200,000 shares of common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

BLACKSKY TECHNOLOGY INC. 10,000,000 Shares of Class A Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • September 25th, 2024 • BlackSky Technology Inc. • Radio & tv broadcasting & communications equipment • New York

BlackSky Technology Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 10,000,000 shares (the “Underwritten Shares”) of Class A common stock, par value $0.0001 per share (“Common Stock”), of the Company and, at the option of the Underwriters, up to an additional 1,500,000 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

CHEWY, INC. 16,666,667 Shares of Class A Common Stock Underwriting Agreement
Underwriting Agreement • September 23rd, 2024 • Chewy, Inc. • Retail-catalog & mail-order houses • New York

Buddy Chester Sub LLC, a Delaware limited liability company (the “Selling Stockholder”), a stockholder of Chewy, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 16,666,667 shares of Class A common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”).

STANDARDAERO, INC. [●] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • September 23rd, 2024 • StandardAero, Inc. • Aircraft engines & engine parts • New York

StandardAero, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares (the “Underwritten Shares”) of common stock, par value $0.01 per share, of the Company (the “Common Stock”). In addition, certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Nuvalent, Inc. Common Stock Underwriting Agreement
Underwriting Agreement • September 17th, 2024 • Nuvalent, Inc. • Pharmaceutical preparations • New York
Legacy Education, Inc. [●] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • September 16th, 2024 • Legacy Education Inc. • Services-educational services • New York

Legacy Education, Inc., a Nevada corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”), for whom Northland Securities, Inc., is acting as the representative (the “Representative”), an aggregate of [●] shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

CSW INDUSTRIALS, INC. 1,100,000 Shares of Common Stock (Including 165,000 Option Shares) Underwriting Agreement
Underwriting Agreement • September 9th, 2024 • CSW Industrials, Inc. • Adhesives & sealants • New York

CSW Industrials, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 1,100,000 shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 165,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

MBX BIOSCIENCES, INC. [•] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • September 9th, 2024 • MBX Biosciences, Inc. • Pharmaceutical preparations • New York

MBX Biosciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Viking Holdings Ltd [•] Ordinary Shares Underwriting Agreement
Underwriting Agreement • September 9th, 2024 • Viking Holdings LTD • Water transportation • New York

Certain shareholders named in Schedule 2 hereto (the “Selling Shareholders”) of Viking Holdings Ltd, an exempted company incorporated with limited liability under the laws of Bermuda (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] ordinary shares, par value $0.01 per share, of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [•] ordinary shares of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The ordinary shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Ordinary Shares.”

HMH Holding Inc. [ ] Shares of Class A Common Stock Form of Underwriting Agreement
Underwriting Agreement • August 26th, 2024 • HMH Holding Inc • Oil & gas field machinery & equipment • Delaware

HMH Holding Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ] shares of Class A common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at

PRECIGEN, INC. 35,294,118 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • August 9th, 2024 • Precigen, Inc. • Pharmaceutical preparations • New York

Precigen, Inc., a Virginia corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 35,294,118 shares (the “Underwritten Shares”) of Common Stock, no par value per share, of the Company (“Common Stock”) and, at the option of the Underwriters, up to an additional 5,294,117 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”. To the extent there are no additional underwriters listed on Schedule 1, the term “Representative” as used herein shall mean you, as Underwriter, and the term “Underwriters” shall mean either the singular or the plural, as the context requires.

Archrock, Inc. 11,000,000 Shares of Common Stock, Par Value $0.01 Per Share Underwriting Agreement
Underwriting Agreement • July 25th, 2024 • Archrock, Inc. • Natural gas transmission • New York

Archrock, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 11,000,000 shares of the common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,650,000 shares of the common stock, par value $0.01 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Concentra Group Holdings Parent, Inc. [ · ] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • July 15th, 2024 • Concentra Group Holdings Parent, Inc. • Services-specialty outpatient facilities, nec • New York

Concentra Group Holdings Parent, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities, Goldman Sachs & Co. LLC and BofA Securities, Inc. are acting as representatives (the “Representatives”), an aggregate of [ · ] shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [ · ] shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Ardent Health Partners, Inc. [ ● ] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • July 10th, 2024 • Ardent Health Partners, LLC • Services-general medical & surgical hospitals, nec • New York

Ardent Health Partners, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ● ] shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [ ● ] shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

AutoNDA by SimpleDocs
DYNEX CAPITAL, INC. 10,500,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • June 7th, 2024 • Dynex Capital Inc • Real estate investment trusts • New York

Dynex Capital, Inc., a Virginia corporation (the “Company”), proposes to issue and sell to the underwriter listed in Schedule 1 hereto (the “Underwriter”), for whom you are acting as representative (the “Representative”), an aggregate of 10,500,000 shares (the “Underwritten Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and, at the option of the Underwriter, up to an additional 1,575,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

WAYSTAR HOLDING CORP. [ ● ] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • May 28th, 2024 • Waystar Holding Corp. • Services-computer integrated systems design • New York

Waystar Holding Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ● ] shares (the “Underwritten Shares”) of common stock, par value $0.01 per share, of the Company (the “Common Stock”) and, at the option of the Underwriters, up to an additional [ ● ] shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

UNDERWRITING AGREEMENT DYNE THERAPEUTICS, INC. 10,500,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • May 22nd, 2024 • Dyne Therapeutics, Inc. • Pharmaceutical preparations • New York

Dyne Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 10,500,000 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,575,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Erasca, Inc. 86,486,486 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • May 17th, 2024 • Erasca, Inc. • Pharmaceutical preparations • New York

Erasca, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC (“JPM”) and BofA Securities, Inc. (“BofA”) are acting as representatives (the “Representatives”), an aggregate of 86,486,486 shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 12,972,972 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

WAYSTAR HOLDING CORP. [ · ] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • May 16th, 2024 • Waystar Holding Corp. • Services-computer integrated systems design • New York

Waystar Holding Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ · ] shares (the “Underwritten Shares”) of common stock, par value $0.01 per share, of the Company (the “Common Stock”) and, at the option of the Underwriters, up to an additional [ · ] shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Bowhead Specialty Holdings Inc. [•] Shares of Common Stock, par value $0.01 per share Underwriting Agreement
Underwriting Agreement • May 13th, 2024 • Bowhead Specialty Holdings Inc. • Fire, marine & casualty insurance • New York

Bowhead Specialty Holdings Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.01 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

GAMES GLOBAL LIMITED [·] Ordinary Shares Underwriting Agreement
Underwriting Agreement • May 10th, 2024 • Games Global LTD • Services-miscellaneous amusement & recreation • New York

Games Global Limited, a limited company incorporated in the Isle of Man (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [·] ordinary shares, nominal value £0.000001 per share (the “ordinary shares”), of the Company, and the shareholder of the Company named in Schedule 2 hereto (the “Selling Shareholder”) proposes to sell to the several Underwriters [·] ordinary shares of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholder proposes to issue and sell, at the option of the Underwriters, up to an additional [·] ordinary shares (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The ordinary shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Ordinary Shares.”

RxSight, Inc. 1,785,714 Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • May 9th, 2024 • RxSight, Inc. • Ophthalmic goods • New York

RxSight, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 1,785,714 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 267,857 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

WAYSTAR HOLDING CORP. [ · ] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • April 29th, 2024 • Waystar Holding Corp. • Services-computer integrated systems design • New York

Waystar Holding Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ · ] shares (the “Underwritten Shares”) of common stock, par value $0.01 per share, of the Company (the “Common Stock”) and, at the option of the Underwriters, up to an additional [ · ] shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Viking Holdings Ltd _____ Ordinary Shares Underwriting Agreement
Underwriting Agreement • April 22nd, 2024 • Viking Holdings LTD • Water transportation • New York

Viking Holdings Ltd, an exempted company incorporated with limited liability under the laws of Bermuda (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ● ] ordinary shares, par value $0.01 per share, of the Company, and certain shareholders of the Company named in Schedule 2 hereto (the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of [ ● ] ordinary shares of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [ ● ] ordinary shares of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The ordinary shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Ord

INTRA-CELLULAR THERAPIES, INC. 7,876,713 Shares of Common Stock (Including 1,027,397 Option Shares) Underwriting Agreement
Underwriting Agreement • April 18th, 2024 • Intra-Cellular Therapies, Inc. • Pharmaceutical preparations • New York

Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 6,849,316 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,027,397 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Stoke Therapeutics, Inc. 5,555,557 Shares of Common Stock and Pre-Funded Warrants to Purchase 3,703,730 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • March 28th, 2024 • Stoke Therapeutics, Inc. • Pharmaceutical preparations • New York

Stoke Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), (i) an aggregate of 5,555,557 shares of common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and (ii) pre-funded warrants to purchase an aggregate of 3,703,730 shares of common stock of the Company, in a form to be mutually agreed by the Company and the Representative (the “Warrants”), and, at the option of the Underwriters, up to an additional 1,388,893 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Warrants are herein referred to as the “Underwritten Securities.” The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The Shares and the Warrants are herein referred to as the “Securities.” The shares of common stock issuable upon exercise of the

Centuri Holdings, Inc. [●] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • March 22nd, 2024 • Centuri Holdings, Inc. • Natural gas transmisison & distribution • New York

Centuri Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of Common Stock, par value $0.01 per share (“Common Stock”), of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [●] shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!